{
    "2020-11-25": [
        [
            {
                "time": "",
                "original_text": "权益变动】泰格医药(03347-HK)被摩根大通减持50.9万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "摩根大通",
                        "减持",
                        "50.9万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "摩根大通减持泰格医药(03347)50.9万股，每股作价135.595港元 减持股份",
                "features": {
                    "keywords": [
                        "摩根大通",
                        "减持",
                        "泰格医药",
                        "135.595港元"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "北向资金连续四日出逃，抛弃白酒股，却看好这一板块（附股）",
                "features": {
                    "keywords": [
                        "北向资金",
                        "出逃",
                        "白酒股",
                        "看好"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒",
                        "其他板块"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】泰格医药(03347-HK)跌4.13%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "跌4.13%"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【医药】阿斯利康新冠疫苗达到主要功效终点，医药进入配置阶段——医药行业周报——中性",
                "features": {
                    "keywords": [
                        "阿斯利康",
                        "新冠疫苗",
                        "主要功效终点",
                        "医药配置"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}